CTTH
CTTH
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
2
$642
Insider Sales
0
$0
Total Volume
$642
2 transactions
Net Activity
+$642
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Ctt Pharmaceutical Holdings, Inc.
CEO
$642 total
Quick Actions
CTTH has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at CTTH (CTTH) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $642.
The net insider activity for CTTH shows a net buying bias of $642. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Ctt Pharmaceutical Holdings, Inc. (CEO), who traded 10.1K shares valued at $455 on Sep 22, 2026.
Consulting fees rose from $5K to $112K as CTT Pharmaceutical (CTTH) posted a wider quarterly loss.
Ctt Pharma CEO Ryan Khouri buys $81 in company stock
CTT Pharmaceutical (CTTH) expects quarterly report within five-day extension.
CTTH 8-K & SEC Filings
CTT Pharmaceutical Adds Karen Larson to Board
Ctt Pharmaceutical Holdings CEO Ryan Khouri buys $450 in shares
FAQs About CTTH Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CTTH.